114 related articles for article (PubMed ID: 26440564)
41. T2-weighted, apparent diffusion coefficient and
Crimì F; Stramare R; Spolverato G; Aldegheri V; Barison A; D'Alimonte L; Bao QR; Spimpolo A; Albertoni L; Cecchin D; Campi C; Quaia E; Pucciarelli S; Zucchetta P
Tech Coloproctol; 2021 May; 25(5):569-577. PubMed ID: 33792823
[TBL] [Abstract][Full Text] [Related]
42. Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer.
Rendl G; Rettenbacher L; Holzmannhofer J; Datz L; Hauser-Kronberger C; Fastner G; Öfner D; Sedlmayer F; Pirich C
Ann Nucl Med; 2015 Apr; 29(3):284-94. PubMed ID: 25503812
[TBL] [Abstract][Full Text] [Related]
43. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
44. The emerging role of FDG PET/CT in rectal cancer management: is it time to use the technique for early prognostication?
Tagliabue L
Eur J Nucl Med Mol Imaging; 2013 May; 40(5):652-6. PubMed ID: 23436074
[No Abstract] [Full Text] [Related]
45. Ineffectiveness of ¹⁸F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer.
Piessen G; Petyt G; Duhamel A; Mirabel X; Huglo D; Mariette C
Ann Surg; 2013 Jul; 258(1):66-76. PubMed ID: 23470576
[TBL] [Abstract][Full Text] [Related]
46. Optimal Interval for
Kawai K; Nozawa H; Hata K; Tanaka T; Nishikawa T; Oba K; Watanabe T
Clin Colorectal Cancer; 2018 Jun; 17(2):e163-e170. PubMed ID: 29208445
[TBL] [Abstract][Full Text] [Related]
47. MRI and FDG-PET for assessment of response to neoadjuvant chemotherapy in locally advanced rectal cancer.
Aiba T; Uehara K; Nihashi T; Tsuzuki T; Yatsuya H; Yoshioka Y; Kato K; Nagino M
Ann Surg Oncol; 2014 Jun; 21(6):1801-8. PubMed ID: 24531702
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis.
Leibold T; Akhurst TJ; Chessin DB; Yeung HW; Macapinlac H; Shia J; Minsky BD; Saltz LB; Riedel E; Mazumdar M; Paty PB; Weiser MR; Wong WD; Larson SM; Guillem JG
Ann Surg Oncol; 2011 Oct; 18(10):2783-9. PubMed ID: 21476107
[TBL] [Abstract][Full Text] [Related]
49. Consequence of restaging after neoadjuvant treatment for locally advanced rectal cancer.
Bisschop C; Tjalma JJ; Hospers GA; Van Geldere D; de Groot JW; Wiegman EM; Van't Veer-Ten Kate M; Havenith MG; Vecht J; Beukema JC; Kats-Ugurlu G; Mahesh SV; van Etten B; Havenga K; Burgerhof JG; de Groot DJ; de Vos Tot Nederveen Cappel WH
Ann Surg Oncol; 2015 Feb; 22(2):552-6. PubMed ID: 25155395
[TBL] [Abstract][Full Text] [Related]
50. Value of metabolic tumor volume on repeated 18F-FDG PET/CT for early prediction of survival in locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
Huang W; Fan M; Liu B; Fu Z; Zhou T; Zhang Z; Gong H; Li B
J Nucl Med; 2014 Oct; 55(10):1584-90. PubMed ID: 25214640
[TBL] [Abstract][Full Text] [Related]
51. Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy.
Capirci C; Rubello D; Chierichetti F; Crepaldi G; Fanti S; Mandoliti G; Salviato S; Boni G; Rampin L; Polico C; Mariani G
AJR Am J Roentgenol; 2006 Aug; 187(2):W202-8. PubMed ID: 16861513
[TBL] [Abstract][Full Text] [Related]
52. Prediction of response to neoadjuvant radiotherapy in patients with locally advanced rectal cancer by means of sequential 18FDG-PET.
Everaert H; Hoorens A; Vanhove C; Sermeus A; Ceulemans G; Engels B; Vermeersch M; Verellen D; Urbain D; Storme G; De Ridder M
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):91-6. PubMed ID: 20605358
[TBL] [Abstract][Full Text] [Related]
53. Tumour hypoxia imaging with 18F-fluoroazomycinarabinofuranoside PET/CT in patients with locally advanced rectal cancer.
Havelund BM; Holdgaard PC; Rafaelsen SR; Mortensen LS; Theil J; Bender D; Pløen J; Spindler KL; Jakobsen A
Nucl Med Commun; 2013 Feb; 34(2):155-61. PubMed ID: 23196674
[TBL] [Abstract][Full Text] [Related]
54. PET-based treatment response evaluation in rectal cancer: prediction and validation.
Janssen MH; Öllers MC; van Stiphout RG; Riedl RG; van den Bogaard J; Buijsen J; Lambin P; Lammering G
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):871-6. PubMed ID: 21377810
[TBL] [Abstract][Full Text] [Related]
55. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging.
Minamimoto R; Mosci C; Jamali M; Barkhodari A; Habte F; Jackson T; Mittra E; Gambhir SS; Iagaru A
J Nucl Med; 2015 May; 56(5):688-94. PubMed ID: 25840978
[TBL] [Abstract][Full Text] [Related]
56. Ku70, Ku80, and sClusterin: A Cluster of Predicting Factors for Response to Neoadjuvant Chemoradiation Therapy in Patients With Locally Advanced Rectal Cancer.
Pucci S; Polidoro C; Joubert A; Mastrangeli F; Tolu B; Benassi M; Fiaschetti V; Greco L; Miceli R; Floris R; Novelli G; Orlandi A; Santoni R
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):381-388. PubMed ID: 28068245
[TBL] [Abstract][Full Text] [Related]
57. Accuracy of endoscopic ultrasound in staging and restaging patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
Marone P; de Bellis M; Avallone A; Delrio P; di Nardo G; D'Angelo V; Tatangelo F; Pecori B; Di Girolamo E; Iaffaioli V; Lastoria S; Battista Rossi G
Clin Res Hepatol Gastroenterol; 2011 Oct; 35(10):666-70. PubMed ID: 21782549
[TBL] [Abstract][Full Text] [Related]
58. Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: long-term results of a prospective trial (National Clinical Trial 00254683).
Perez RO; Habr-Gama A; Gama-Rodrigues J; Proscurshim I; Julião GP; Lynn P; Ono CR; Campos FG; Silva e Sousa AH; Imperiale AR; Nahas SC; Buchpiguel CA
Cancer; 2012 Jul; 118(14):3501-11. PubMed ID: 22086847
[TBL] [Abstract][Full Text] [Related]
59. Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET.
Capirci C; Rubello D; Chierichetti F; Crepaldi G; Carpi A; Nicolini A; Mandoliti G; Polico C
Biomed Pharmacother; 2004 Oct; 58(8):451-7. PubMed ID: 15464875
[TBL] [Abstract][Full Text] [Related]
60. Positron emission tomography detection of distant metastatic or synchronous disease in patients with locally advanced rectal cancer receiving preoperative chemoradiation.
Nahas CS; Akhurst T; Yeung H; Leibold T; Riedel E; Markowitz AJ; Minsky BD; Paty PB; Weiser MR; Temple LK; Wong WD; Larson SM; Guillem JG
Ann Surg Oncol; 2008 Mar; 15(3):704-11. PubMed ID: 17882490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
